Risks associated with new drugs and medical devices challenge expectations for progress in medicine and can undermine public trust in industry, physicians, and the government. While international efforts have been made to ensure safety in medicine, the contexts in which medical innovations take place create different understandings of acceptable risks. To better understand these issues, this year’s Cain Conference addresses a set of related questions: How do risk perception and response differ among key actors and institutions (inventors, manufacturers, statisticians, regulators, physicians, patients, and the media)? What types of evidence are used to decide on risk and safety? Who has the power to decide whether a procedure, drug, or device is risky or safe? The talks help explain the historical development of modern notions of risk and safety while emphasizing their contingent and context-dependent character. They also will provide a comparative background for evaluating contemporary problems in medical innovation.
Conference program and registration materials are available at our website.
For additional information, please contact:
Arthur Daemmrich, Policy Analyst
Chemical Heritage FOundation
315 Chestnut Street
Philadelphia PA 19106
Send comments and questions to H-Net
Webstaff. H-Net reproduces announcements that have been submitted to us as a
free service to the academic community. If you are interested in an announcement
listed here, please contact the organizers or patrons directly. Though we strive
to provide accurate information, H-Net cannot accept responsibility for the text of
announcements appearing in this service. (Administration)